Anticancer Fund: Changemakers on a mission

Unique research and cures

We support the high-impact cancer research others overlook to find better treatments for every patient. Our clinical trials prioritise patient survival and quality of life over financial returns. Discover the non-commercial solutions that are changing the future of cancer care.

The focus of Anticancer Fund

Clinical research

We challenge the status quo by funding innovative clinical trials, like repurposing common, affordable medicines for complex cancers. Learn how we are maximizing existing resources to find effective solutions for cancer therapies

https://www.anticancerfund.org/en/clinical-research/our-research-focus

Patient information

Every patient deserves clear answers. Reach out to the physicians and scientists of My Cancer Navigator for free, science-based information about your specific cancer and treatment options.

https://www.mycancernavigator.org/en

Discover our latest news

Exercise as medicine: physical activity is vital before, during, and after cancer

Can physical activity actually improve cancer outcomes? Prof. Dr. Nele Adriaenssens (VUB/UZ Brussel) shares why exercise is a "gamechanger" for cancer patients, from reducing chemotherapy side effects to lowering recurrence risks. Learn why personalised rehabilitation is essential before, during, and after treatment in this interview.

13 February 2026

Concentration of complex cancer care saves lives

New Belgian research, funded by Anticancer Fund and Kom op tegen Kanker, demonstrated that patients with uterine cancer have a significantly better survival rate when treated in hospitals with sufficient experience and expertise. These findings come from the EFFECT study, led by Prof. Dr. Frédéric Amant (University Hospital Leuven), and emphasize the importance of concentrating complex cancer care in specialized centers.

30 January 2026

Hot flush treatment has anti-breast cancer activity, study finds

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a trial coordinated by the University of Cambridge has found.

5 January 2026

Breast cancer patients often receive unnecessary new cancer drugs

Not all cancer patients benefit from new drugs. To study which patients really do, doctors and researchers need access to the clinical data and tissue samples that patients provide in clinical studies. An international group of 53 breast cancer experts and patients representatives is therefore calling for better cooperation between academic institutions and the pharmaceutical sector. Their claim has been published in JAMA Oncology.

19 December 2025